VivoSeq
Oncology

Abdominal Cancer Surgery

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Abdominal Cancer Surgery is an early-stage landscape with 0 programs across 1 company. The most active players are Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Sanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Unknown status3 · 50%
Completed2 · 33%
Active, not recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial
Active, not recruiting·MM.D. Anderson Cancer Center·Phase 2·NCT06232577·170 enrolled
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Completed·Sanofi logoSanofi·Phase 3·NCT00723216·151 enrolled
intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain
Completed·—·Phase 2/3·NCT02726828·90 enrolled
Safety and Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Ultra-sound Guided Transversus Abdominis Plan Block in Pediatric Abdominal Cancer Surgery
Unknown status·SSouth Egypt Cancer Institute·Phase 3·NCT03979599·10 enrolled
Aalgesic Efficacy of Erector -Spinae Technique With Levobupvicaine in Patients Undergoing Upper Abdominal Cancer Surgery
Unknown status·SSouth Egypt Cancer Institute·Phase 1·NCT04315454·30 enrolled
Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain
Unknown status·—·Phase 2/3·NCT02455609·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)